Drug class in one race
Glucagon receptor (agonist) drugs for Type 2 Diabetes
2 tracked Glucagon receptor (agonist) drugs in the Type 2 Diabetes race. The class explanation lives on the Glucagon receptor (agonist) page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.
1 Phase 11 preclinical / unstaged
Head-to-head evidence: dasiglucagon vs Nasal Glucagon